Matthias Bodenstedt serves as Executive at MoonLake Immunotherapeutics, where they oversee executive responsibilities. Since joining the company, Matthias Bodenstedt has executed 11 insider transactions totaling $6.0M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 19, 2025 involved selling 294,473 shares valued at $0.
Matthias Bodenstedt currently holds 922,009 shares of MoonLake Immunotherapeutics (MLTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthias Bodenstedt has been a net seller of MLTX stock. They have purchased $98.8K and sold $5.9M worth of shares.
Matthias Bodenstedt's most recent insider trade was on Dec 19, 2025, when they sold 294,473 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 8, 2025 | MLTX | $98.8K | Purchase | 10,870 | $9.09 | Discretionary |
| Dec 20, 2023 | MLTX | $307.1K | Sale | 5,264 | $58.34 | Planned |
| Dec 19, 2023 | MLTX | $5.6M | Sale | 94,736 | $59.22 | Planned |
| Oct 1, 2023 | MLTX | $0 | Conversion | 62,972 | $N/A | Discretionary |
| Oct 1, 2023 | MLTX | $0 | Disposition | 62,972 | $N/A | Discretionary |
| Apr 5, 2023 | MLTX | $0 | Conversion | 147,135 | $N/A | Discretionary |
| Apr 5, 2023 | MLTX | $0 | Disposition | 147,135 | $N/A | Discretionary |
| Apr 5, 2023 | MLTX | $0 | Conversion | 410,796 | $N/A | Discretionary |
| Apr 5, 2023 | MLTX | $0 | Disposition | 410,796 | $N/A | Discretionary |